Biotech Scoreboard, November: Gene Therapy Stocks Gain Momentum

By Rod Raynovitch of Roadmap2Retire

CEO of Raygent Associates • Nov 30, 2019 at 11:38 PM EST

IBB is up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %. The big winners for the month include NTLA up 47.24%.

Here is the review we did on June 30 after a Barron’s article on the sector.

IBB up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %.

Big Winners for the Month: NTLA up 47.24%, EDIT up 41.5%, CRSP up 37.68%, SRPT up 34%,



Company	Symbol	Price	Price at		Price	Mo./%	YTD %
		6/29/19	52 wk hi		11/30

Audentes Therap	BOLD	37.86	42.7	1.67	29.03	14.5	30.71
MetraGTx	MGTX	26.88	27	0.896	19.27	10.2	95.93
RegenexBio	RGNX	51.37	85.1	1.88	41.86	21.2	(3.390
Solid Biosci	SLDB	5.75	54.54	0.37	3.93	-65.13	-86.41
uniQure	QURE	78.15	82.49	2.95	55.66	14.5	95
Voyager Therap	VYGR	27.22	28.79	0.612	13.64	14.49	44.8

Diversified Plays

Biomarin	BMRN	85.65	106.74	15.337	80.71	9.8	-5
Sarepta	SRPT	151.95	165.87	11.27	112.49	34.04	4.64

Other

Amicus	FOLD	12.48	16.82	3.174	10.48	26.4	4.36
bluebird bio	BLUE	127.2	183.6	7.012	80.94	-2.7	-18.65

Gene Editing

CRSPR Therap	CRSP	47.1	66.26	2.58	71.65	37.68	139.87
Editas Medicine	EDIT	24.74	38.77	1.22	30.28	41.5	29.73
Intellia Therap	NTLA	16.37	35.3	0.748	17.33	47.24	25.5
Sangamo Ther	SGMO	10.77	-3.9	1.24	10.8	16.8	-8.32
Cellectis S.A.	CLLS				13.9	16	-19.94

IBB		109.1	122.97		119.65	11.2	22.72
XBI		87.71	101.17		93.65	6.3	28.53

QQQ					205.17	14.5	32.43

Disclosure:

None.

STOCKS IN THIS ARTICLE

IBB QQQ XBI SRPT NTLA CRSP

Comments

Back to all articles